Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Tract/Bladder Cancer, Nos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04099589
What this trial is testing

Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma

Who this might be right for
Upper Tract Urinary CarcinomaMuscle-invasive Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 64
Not applicableLooking for participantsNCT07643558
What this trial is testing

Effects of Dietary Supplementation With omega3-fatty Acids (Fish Oil) and Progressive Resistance Training on Skeletal Muscle Status in Gynaecological, Gastrointestinal and Urological Cancer Patients

Who this might be right for
Cancer CachexiaOmega 3Resistance Training+3 more
University of Erlangen-Nürnberg Medical School 288
Early research (Phase 1)Active Not RecruitingNCT06337084
What this trial is testing

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultBladder CancerUrothelial Carcinoma+6 more
Monopar Therapeutics 12
Early research (Phase 1)UnknownNCT05311618
What this trial is testing

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827612
What this trial is testing

Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cancer

Who this might be right for
Urinary Bladder NeoplasmsUrologic NeoplasmsReceptor, Fibroblast Growth Factor, Type 3
Eli Lilly and Company 161
Early research (Phase 1)Ended earlyNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Early research (Phase 1)Active Not RecruitingNCT04731376
What this trial is testing

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Who this might be right for
HypogonadismMalignant Urinary System NeoplasmUrinary System Disorder+1 more
Emory University 56
Early research (Phase 1)Study completedNCT02836795
What this trial is testing

Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors

Who this might be right for
MelanomaUrological Cancer
Shanghai Junshi Bioscience Co., Ltd. 35
Testing effectiveness (Phase 2)Looking for participantsNCT07186842
What this trial is testing

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Who this might be right for
Advanced Solid Cancers
BioNTech SE 245
Testing effectiveness (Phase 2)Looking for participantsNCT06760819
What this trial is testing

Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Solid TumorsHER2 Mutation
Bayer 111
Testing effectiveness (Phase 2)UnknownNCT05038657
What this trial is testing

Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).

Who this might be right for
Squamous Cell CarcinomaUrinary Tract Cancer
University Hospital Southampton NHS Foundation Trust 36
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Not applicableLooking for participantsNCT06398314
What this trial is testing

Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors

Who this might be right for
Gastrointestinal CancerUrologic CancerGynecologic Cancer
Sykehuset Telemark 200
Testing effectiveness (Phase 2)Looking for participantsNCT06161532
What this trial is testing

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Who this might be right for
Small Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Ended earlyNCT04197986
What this trial is testing

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Who this might be right for
Upper Tract Urothelial CarcinomasUrothelial Bladder Cancer
QED Therapeutics, a BridgeBio company 39
Not applicableLooking for participantsNCT07634666
What this trial is testing

Prediction of Myocardial Injury After Non-Cardiac Surgery in Urologic Cancer Patients

Who this might be right for
Myocardial Injury After Non-cardiac SurgeryUrologic CancerMajor Adverse Cardiovascular Events (MACE)
Korea University Anam Hospital 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07464145
What this trial is testing

NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Urothelial Carcinoma Bladder+2 more
Relmada Therapeutics, Inc. 393
Not applicableLooking for participantsNCT07416630
What this trial is testing

Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

Who this might be right for
Gynecologic CancerUrologic CancerBreast Cancer
Institute of Oncology Ljubljana 30
Not applicableUnknownNCT06564363
What this trial is testing

The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Wuhan Ammunition Life-tech Co., Ltd 148
Very early researchStudy completedNCT03071328
What this trial is testing

INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Urothelial CarcinomaMetastatic Renal Cell Carcinoma
Duke University 10
Next Page
60